Advertisement

Topics

Glycosan BioSystems, Inc. Company Profile

23:05 EDT 23rd September 2017 | BioPortfolio


News Articles [116 Associated News Articles listed on BioPortfolio]

T2 Biosystems nets $16.5mm via FOPO

Diagnostics firm T2 Biosystems Inc. netted $16.45mm through the follow-on sale of 4.38mm common shares at $4.

CDC, T2 Biosystems team up on Candida auris testing, monitoring

T2 Biosystems and the CDC entered into a collaboration enabling the CDC to use T2's T2Dx instrument for the testing and monit -More- 

Akonni Biosystems gets $4M boost

Bridge financing worth $4 million has been secured by Frederick, Md.-based molecular diagnostics firm Akonni Biosystems.  -More- 

EU OKs bacterial panel from T2 Biosystems

T2 Biosystems' T2Bacteria Panel has been granted CE mark approval by European regulators.  -More- 

Applied Biosystems 2720 Thermal Cycler 96 well

$79.99 (0 Bids)End Date: Monday May-29-2017 8:05:38 PDTBid now | Add to watch list Biotech365 : Applied Biosystems 2720 Thermal Cycler 96 well BioMarketplace You want to propose your products or ...

TARA Biosystems Taps MyoKardia’s Michael Graziano for CSO Post

Michael Graziano is joining TARA Biosystems to become the New York company’s chief scientific officer. TARA Biosystems is developing “heart-on-a-chip” tissue models that can be used in drug dis...

Imagion Biosystems closes $A12mm IPO on ASX

Imagion Biosystems Ltd. (cancer detection) grossed $A12mm ($9mm) through its initial public offering on the Australian Securities Exchange of 60mm new shares at $A0.20.

Applied BioSystems 9800 Fast Thermal Cycler

$1,999.99End Date: Sunday Aug-6-2017 20:32:53 PDTBuy It Now for only: $1,999.99Buy It Now | Add to watch list Biotech365 : Applied BioSystems 9800 Fast Thermal Cycler BioMarketplace You want to p...

Drugs and Medications [0 Results]

None

PubMed Articles [54 Associated PubMed Articles listed on BioPortfolio]

Back cover.

Contents list.

Front cover.

Second law efficiency for living cells.

The exergetic analysis of the biosystems is developed. It takes into account that cells are able to convert only part of the energy absorbed. The result is to highlight the fundamental role of the exe...

PowerPlex® Fusion 6C System: evaluation study for analysis of casework and database samples.

To report on the successful analysis of amplicons obtained with PowerPlex® Fusion 6C System, a highly robust 27-plex genotyping kit developed for human identification laboratories, on the Applied Bio...

Clinical Trials [0 Results]

None

Companies [102 Associated Companies listed on BioPortfolio]

Glycosan BioSystems, Inc.

X2 Biosystems

X2 Biosystems is a privately held Seattle-based science and technology company that has developed the world’s first systems for comprehensive, end-to-end, real-time managemen...

Silicon Biosystems, Inc.

Silicon Biosystems, Inc. was formed in October of 2010 as a wholly owned subsidiary of Silicon Biosystems, S.p.A. based in Bologna, Italy. The Company manufactures and sells the D...

Syntrix Biosystems, Inc.

Syntrix Biosystems, Inc., is a private, Washington-based biotechnology company dedicated to developing and commercializing therapeutic compounds and research platforms for the pha...

Kapa Biosystems

Kapa Biosystems is a next-generation life science reagents supplier that employs high-throughput molecular evolution to optimize enzymes for DNA amplification, next-generation DNA...

More Information about "Glycosan BioSystems, Inc." on BioPortfolio

We have published hundreds of Glycosan BioSystems, Inc. news stories on BioPortfolio along with dozens of Glycosan BioSystems, Inc. Clinical Trials and PubMed Articles about Glycosan BioSystems, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glycosan BioSystems, Inc. Companies in our database. You can also find out about relevant Glycosan BioSystems, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record